Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
31 Octobre 2022 - 01:14PM
Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and
innovator in seed brachytherapy powering expanding treatment
options throughout the body, today announced that it will host a
conference call to discuss its financial results for the first
quarter fiscal 2023 ended September 30, 2022 on Thursday, November
10, 2022, at 4:30 p.m. Eastern Time. The Company will issue a press
release announcing its financial results for the first quarter
fiscal year 2023 after the close of the U.S. stock markets on
November 10, 2022.
To listen to the conference call, please dial (877) 545-0320.
For callers outside the U.S., please dial (973) 528-0002.
The conference call will be simultaneously webcast and can be
accessed at https://www.webcaster4.com/Webcast/Page/2199/46923. The
webcast will be available until February 10, 2023 following the
conference call.
About IsorayIsoray, Inc. is a medical
technology company pioneering advanced treatment applications and
devices to deliver targeted internal radiation treatments for
cancers throughout the body. Isoray, Inc., through its subsidiary,
Isoray Medical, Inc., is the sole producer of Cesium-131
brachytherapy seeds. Learn more about this innovative Richland,
Washington company and explore the many benefits and uses of
Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and
Twitter.
Contact
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
IsoRay (AMEX:ISR)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024